Medicated skin care products help in overcoming various skin related problems by wounding skin healings with the help of its anti-inflammatory and other useful medical properties. Medicated skin care products are also used to treat various skin related issues such as psoriasis, eczema, dry skin, and dermatitis. They come in various forms including cleansers, face and body moisturizers, hand & foot creams, scrubs, lip care, and hand sanitizers, among others. Medicated skin care products calm the irritated and inflamed skin while restoring weakened skin with essential natural and artificial ingredients. Medicated skin care products are infused with various ingredients, which are vital for the process of skin healing. For instance, Madecassoside is an active skin care ingredient derived from the plant Centella asiatica. Centella asiatica is a medicinal plant that has been used in Ayurveda medicine in India for several years. Madecassoside has various anti-aging as well as skin healing properties.

Increasing skin problems such as eczema among people across the globe due to increase in pollution, and rising awareness among the masses about skin care and its advantages are some of the factors driving the growth of the global medicated skin product market. There has been increase in the number of people who suffer from eczema globally. Eczema is a skin condition that can cause extremely itchy, scaly, and dry skin. In March 2017, New York Times reported that more than 300,000 people in the U.S. have acute eczema. There are various medicated skin care products that comes in the form of moisturizers and ointments to overcome eczema and other related disorders. Medicated skin care products boosts the feel and look of skin plumpness, while improving the appearance of pores, redness, and wrinkles. It helps the skin to look younger. Currently, people across the globe are more aware about various skin related problems. This awareness is pushing them to use medicated skin care products including acne creams, anti-aging solutions, and moisturizers, among others.

High cost of certain medicated skin care products and presence of low quality skin care products in the market could restrain the growth of the global medicated skin care product market. However, increased awareness among the people about the harmful skin related problems and increased purchasing power is projected to overcome these restraints in the near future.

Presence of pharmaceutical drug regulators, ensuring the superior quality of medicated skin care products are creating opportunities for the global medicated skin care products market. Drug regulators such as the U.S. Food and Drug Administration (FDA), perform regular site inspection of drug makers to make sure the quality of drugs is maintained. For instance, in April 2017, Indian drug maker company Lupin Limited received a warning letter from the FDA for its Goa unit where quality lapses were observed.

The medicated skin care product market can be segmented on the basis of product type, condition, user, and regions. On the basis of product type, the medicated skin care product market can be segmented into antiseptic, body moisturizer, body wash, face cream, hair treatment, hand cream, and others. On the basis of condition type, the market can be segmented into acne, after sun, anti-inflammatory, bruising, dry skin, sensitive skin, and others. Furthermore, on the basis of user type, the market can be segmented adult, child, infant, teenager, and women.

Geographically, the medicated skin care product market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America and Europe are expected to lead due to the presence of prominent players from the medicated skin care product market. However, the market in Asia Pacific is expected to expand at a significant pace due to the increasing incidence of skin diseases due to the rising pollution and temperature levels across countries such as China and India.

Some of the key players in the medicated skin care product market are Bayer, Pfizer Inc., Unilever, Otsuka Holdings Co., Ltd., Baxter Laboratories Pty Ltd, Johnson & Johnson Private Limited, Beiersdorf AG, Kao Corporation, Taisho Pharmaceutical Co., Ltd., Merz, Inc., and more.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market 

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.